A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Clinical trial NCT07400029 · RECRUITING
Trial details
- NCT number
- NCT07400029
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-03
- Primary completion
- 2029-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.